Highlights NEXGEL, Inc.

Equities

NXGL

US65344E1073

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-10 pm EDT			5-day change	1st Jan Change
2.16 ^USD	+1.89%		+0.93%	+1.41%

May. 16	NEXGEL, Inc. acquired Silly George.	CI
May. 13	NEXGEL, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NEXGEL, Inc. acquired Silly George.	May. 15	CI
NEXGEL, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 13	CI
Earnings Flash (NXGL) NEXGEL Reports Q1 Revenue $1.3M, vs. Street Est of $1.2M	May. 13	MT
NEXGEL, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 01	CI
Earnings Flash (NXGL) NEXGEL Posts Q4 Revenue $1.1M	Apr. 01	MT
NEXGEL, Inc. Provides Revenue Guidance for the First Quarter of 2023	Apr. 01	CI
Nexgel Subsidiary, Cg Converting and Packaging, Begins 12,000 Square Foot Expansion of Texas Facility to Support the Expected Growth in Product Demand in 2024	Jan. 09	CI
Nexgel Enters Deal With Stada Arzneimittel to Distribute OTC Products Across North America	Dec. 11	MT
NEXGEL, Inc. Announces Partnership with STADA Arzneimittel AG to Distribute and Commercialize Consumer Health OTC Products in North America	Dec. 11	CI
NEXGEL, Inc. acquired Kenkoderm from Olympus Trading Company, LLC for $1.1 million.	Dec. 04	CI
Tranche Update on NEXGEL, Inc.'s Equity Buyback Plan announced on December 7, 2022.	Nov. 13	CI
NEXGEL, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
Earnings Flash (NXGL) NEXGEL Reports Q3 Revenue $1.2M, vs. Street Est of $1.2M	Nov. 13	MT
NEXGEL Unit Executes Supply Agreement with AbbVie	23-10-30	MT
NEXGEL, Inc. Secures Supply Agreement with AbbVie Inc	23-10-30	CI
Tranche Update on NEXGEL, Inc.'s Equity Buyback Plan announced on December 7, 2022.	23-08-14	CI
NEXGEL, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Earnings Flash (NXGL) NEXGEL Reports Q2 Revenue $1.2M, vs. Street Est of $1M	23-08-14	MT
NEXGEL Partners With Enigma Health for Retail Distribution, Marketing Services in North America	23-07-19	MT
Tranche Update on NEXGEL, Inc.'s Equity Buyback Plan announced on December 7, 2022.	23-05-15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights NEXGEL, Inc.

Equities

NXGL

US65344E1073

Highlights

Filters